You have set your browser to not allow cookies. This means that some functions on the website do not work.

Go to main content

This page in Swedish

Lovisa Bergengren

Position: Affiliated Researcher School/office: School of Medical Sciences

Email: lovisa.bergengren@oru.se

Phone: No number available

Room: -

Research subject

Surgical Science

About Lovisa Bergengren

Lovisa Bergengren works as a senior consultant at the department of Women's health at Örebro University Hospital, with a specialization in obstetrics and gynaecolgy. She is responsible for the cervical screening programme in the Region of Örebro County; is the process leader of cervical screening in RCC Uppsala Örebro and represents the region in the national working group for prevention of cervical cancer, NACx; and is a memeber of the Swedish National Cervical Screening Registry steering committee.

Research

PhD from Örebro University 2020 "Cervical screening with primary HPV - from research to clinical effectiveness". Research area is strategies for HPV screening to identify women at highest risk for cervical cancer.

Active projects

Research groups

Contraception and menopusal hormone treatment

Publications

Articles in journals | Conference papers | Doctoral theses, comprehensive summaries | Manuscripts |

Articles in journals

Helenius, G. , Lillsunde-Larsson, G. & Bergengren, L. (2023). Molecular triage of cervical screening samples in women 55-59 years of age: a pilot study. Infectious Agents and Cancer, 18 (1).
Bergengren, L. , Ryen, L. , Flodström, C. , Fadl, H. , Udumyen, R. , Karlsson, M. G. & Helenius, G. (2022). Effectiveness and costs of an implemented primary HPV cervical screening programme in Sweden: A population based cohort study. Preventive Medicine Reports, 25.
Kaliff, M. , Lillsunde-Larsson, G. , Helenius, G. , Karlsson, M. & Bergengren, L. (2022). Full genotyping and FAM19A4/miR124-2 methylation analysis in high-risk human papillomavirus-positive samples from women over 30 years participating in cervical cancer screening in Örebro, Sweden. PLOS ONE, 17 (9).
Jans, L. , Zetterström, K. , Bergengren, L. & Helenius, G. (2021). The value of adding a single co-test in HPV primary screening. Preventive Medicine, 149.
Bergengren, L. , Karlsson, M. & Helenius, G. (2020). Prevalence of HPV and pathological changes among women 70 years of age, 10 years after exclusion from the Swedish cervical cancer screening program. Cancer Causes and Control, 31 (4), 377-381.
Bergengren, L. , Lillsunde-Larsson, G. , Helenius, G. & Karlsson, M. G. (2019). HPV-based screening for cervical cancer among women 55-59 years of age. PLOS ONE, 14 (6).
Bergengren, L. , Kaliff, M. , Lillsunde-Larsson, G. , Karlsson, M. & Helenius, G. (2018). Comparison between professional sampling and self-sampling for HPV-based cervical cancer screening among postmenopausal women. International Journal of Gynecology & Obstetrics, 142 (3), 359-364.
Lillsunde Larsson, G. , Kaliff, M. , Bergengren, L. , Karlsson, M. G. & Helenius, G. (2016). HPV Genotyping from the high risk mRNA Aptima assay: a direct approach using DNA from Aptima sample tubes. Journal of Virological Methods, 235, 80-84.

Conference papers

Bergengren, L. (2023). Full genotyping and FAM19A4/miR124-2 methylation analysis in high-risk humanpapillomavirus-positive samples from women over 30 years participating in cervical cancerscreening in Örebro, Sweden. In: Shaped Challenges of HPV Driven Cancers From Research to Practice. Paper presented at EUROGIN 2023, Bilbao, Portugal, February 8-11, 2023.
Kaliff, M. , Bergengren, L. , Helenius, G. , Karlsson, M. & Lillsunde-Larsson, G. (2019). DNA methylation analysis in HPV-positive screening samples from women 30-69 years in the cervical cancer-screening program in Örebro, Sweden: a pilot study. In: EUROGIN 2019 ABSTRACTS POSTERS. Paper presented at EUROGIN 2019: International Multidisciplinary HPV Congress, Monaco, December 4-7, 2019.
Helenius, G. , Lillsunde-Larsson, G. , Bergengren, L. , Kaliff, M. & Karlsson, M. (2019). Preliminary data from a Swedish self-sampling study in postmenopausal women. Paper presented at EUROGIN 2019 – International Multidisciplinary HPV Congress, Monte Carlo, Monaco, December 4-7, 2019.
Helenius, G. , Ottestig, E. , Kaliff, M. , Lillsunde-Larsson, G. , Karlsson, M. & Bergengren, L. (2018). Distribution of HPV-genotypes in a Swedish screening population. Paper presented at Eurogin 2018 International multidisciplinary HPV Congress, Lisabon Portugal, December 2-5, 2018.
Bergengren, L. (2017). HPV INFECTION AMONG ELDERLY WOMEN: a population based cohort study. Paper presented at Eurogin, Amsterdam, the Netherlands, 2017.
Bergengren, L. , Lillsunde-Larsson, G. , Kaliff, M. , Karlsson, M. & Helenius, G. (2016). Concordance between self sampling and professionally taken cervical hpv test-result from population based cohort study. Paper presented at Eurogin, Salzburg, Austria, 2016.
Bergengren, L. (2015). Prevalence of HPV low and high risk genotypes in older women in Sweden: first results from a population based cohort study. Paper presented at Eurogin, Lissabon, Portugal, 2015.

Doctoral theses, comprehensive summaries

Bergengren, L. (2020). Cervical screening with primary HPV: from research to clinical effectiveness. (Doctoral dissertation). (Comprehensive summary) Örebro: Örebro University.

Manuscripts

Bergengren, L. , Ryen, L. , Flodström, C. , Fadl, H. , Udumyan, R. , Karlsson, M. & Helenius, G. Effectiveness and costs of implemented primary HPV cervical screening : a populationbased cohort study.
Kaliff, M. , Ekman, M. , Ottestig, E. , Helenius, G. , Bergengren, L. , Karlsson, M. G. & Lillsunde-Larsson, G. Full genotyping and FAM19A4/miR124-2 methylation analysis in high-risk HPV-positive samples from women over 30 years participating in cervical cancer screening in Örebro, Sweden.